Page 582«..1020..581582583584..590600..»

The Crohn’s & Colitis Foundation Western Pennsylvania/West Virginia Chapter Hosts Third Annual Night of Steel Fundraising Event – Citybizlist

Posted: Published on October 8th, 2020

Night of Steel Presented by UPMC and UPMC Health Plan HonorsLocal Volunteer, Rachel Stackiewicz, and Allegheny Health Network CEO, Cynthia Hundorfean The Crohns & Colitis Foundation Western Pennsylvania/West Virginia chapter invites the community to the third annual Night of Steel premier fundraising event on Saturday, Oct. Continue reading →

Posted in Ulcerative Colitis | Comments Off on The Crohn’s & Colitis Foundation Western Pennsylvania/West Virginia Chapter Hosts Third Annual Night of Steel Fundraising Event – Citybizlist

US Inflammatory Bowel Disease (IBD) Therapeutics Market share, trends, size, research and forecast 2019-2025 edited by leading research firm – WhaTech

Posted: Published on October 8th, 2020

US Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Share & Trends Analysis Report by Disease Type (Ulcerative Colitis and Crohns Disease), By Treatment Type (Surgery and Anti- Inflammatory Drug Administration) and Forecast 2019-2025. The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. Continue reading →

Posted in Ulcerative Colitis | Comments Off on US Inflammatory Bowel Disease (IBD) Therapeutics Market share, trends, size, research and forecast 2019-2025 edited by leading research firm – WhaTech

‘Stoma surgery saved my life’: Aberdeen mum tells of battle with invisible illness on World Ostomy Day – Aberdeen Evening Express

Posted: Published on October 8th, 2020

Ulcerative colitis, dubbed an invisible illness, leaves sufferers while seemingly fine on the outside experiencing excruciating pain. Continue reading →

Posted in Ulcerative Colitis | Comments Off on ‘Stoma surgery saved my life’: Aberdeen mum tells of battle with invisible illness on World Ostomy Day – Aberdeen Evening Express

What are the side effects of Trump’s coronavirus treatment regimen? | TheHill – The Hill

Posted: Published on October 8th, 2020

Following President Trumps coronavirus diagnosis, he has been given an experimental antibody treatment not yet approved for broad use, a course of an antiviral drug shown to help hospitalized coronavirus patients and a steroid typically used for severe COVID-19 cases. White House physician Sean Conley on Friday afternoon announced Trump was given a single 8-gram dose of biotechnology company Regenerons experimental antibody cocktail named REGN-COV2. Continue reading →

Posted in Ulcerative Colitis | Comments Off on What are the side effects of Trump’s coronavirus treatment regimen? | TheHill – The Hill

Concussion Market Size Worth $8.9 Billion By 2027 | CAGR: 3.6%: Grand View Research, Inc. – PRNewswire

Posted: Published on October 8th, 2020

SAN FRANCISCO, Oct. 7, 2020 /PRNewswire/ -- The global concussion marketsize is anticipated to reach USD 8.9 billion by 2027, expanding at a CAGR of 3.6%, according to a new report by Grand View Research, Inc. Increasing number of injuries being caused to the brain resulting in a high prevalence of associated disorders such as concussion is driving the market in a positive manner. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Concussion Market Size Worth $8.9 Billion By 2027 | CAGR: 3.6%: Grand View Research, Inc. – PRNewswire

Province Investing $25,000 to Prevent and Treat Brain Injuries in BGOS – The Meaford Independent

Posted: Published on October 8th, 2020

Ontario is supporting concussion research with an investment of $25,000 to the Concussion Legacy Foundation Canada (CLFC) to prevent and manage the treatment of brain injuries in Bruce-Grey-Owen Sound. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Province Investing $25,000 to Prevent and Treat Brain Injuries in BGOS – The Meaford Independent

Woman hit by vehicle in Asda car park ‘died of brain injury’ – Dorset Echo

Posted: Published on October 8th, 2020

A RETIRED woman who was hit by a car in a supermarket car park died of a brain injury, an inquest heard. Susan Stanford, of Borley Road, Poole, was taken to Poole Hospital following the incident on Friday, September 18. The 69-year-old was transferred to Southampton General Hospital but her condition deteriorated and she died on Saturday, September 26. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Woman hit by vehicle in Asda car park ‘died of brain injury’ – Dorset Echo

A Grand Initiative to Improve Coma Care in Disorders of… : Neurology Today – LWW Journals

Posted: Published on October 8th, 2020

By Mark Moran October 8, 2020 The Science Explained Article In Brief The Society of Neurocritical Care has launched a new campaign to encourage research that enables clinicians to better understand not only acute coma but also disorders of consciousness broadly, including patients with altered consciousness. Efforts will also focus on better understanding the anatomical and physiological commonalities across disorders Continue reading →

Posted in Brain Injury Treatment | Comments Off on A Grand Initiative to Improve Coma Care in Disorders of… : Neurology Today – LWW Journals

Global Sports Medicine Market Is Expected to Reach USD 7.9 Billion by 2027 : Fior Markets – GlobeNewswire

Posted: Published on October 8th, 2020

October 06, 2020 13:00 ET | Source: Fior Markets Newark, NJ, Oct. 06, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, theglobal sports medicine market is expected to grow from USD 5.2 billion in 2019 to USD 7.9 billion by 2027, at a CAGR of 5.5% during the forecast period 2020-2027. Sports medicine comes under a branch of healthcare that includes enhancing an athlete's on-field performance Continue reading →

Posted in Brain Injury Treatment | Comments Off on Global Sports Medicine Market Is Expected to Reach USD 7.9 Billion by 2027 : Fior Markets – GlobeNewswire

AlzeCure gets abstract on the Alzstatin platform against Alzheimer’s accepted for poster presentation at CTAD – PR Newswire UK

Posted: Published on October 8th, 2020

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company has received an abstract approved for poster presentation at the annual Alzheimer's conference CTAD, Clinical Trials in Alzheimer's Disease, which this year will be held completely digitally on November 4-7 Continue reading →

Posted in Brain Injury Treatment | Comments Off on AlzeCure gets abstract on the Alzstatin platform against Alzheimer’s accepted for poster presentation at CTAD – PR Newswire UK

Page 582«..1020..581582583584..590600..»